Anaemia and its treatment in neurologically critically ill patients: being reasonable is easy without prospective trials.
Most healthy humans have a haemoglobin concentration of 12 to 15 g/dL and most intensivists now transfuse packed red blood cells for haemoglobin <7 g/dL. Higher haemoglobin is associated with improved intermediate and clinical outcomes after subarachnoid hemorrhage (from ruptured brain aneurysm) or neurotrauma. An observational study in a recent issue shows that higher haemoglobin was associated with better functional outcomes in patients with spontaneous intracerebral haemorrhage; few patients received a packed red blood cell transfusion, so it is not known if that treatment is better than the disease. The mechanism of anaemia's purported impact on outcome is unclear, although altered metabolism in brain tissue that is sensitive to reduced oxygen delivery is plausible. These data may intensify the differences of opinion between intensivists: whether neurologic patients are better served by higher haemoglobin and potentially by more packed red blood cell transfusion, or simply need to be studied more in prospective clinical trials, remains unclear.
Naidech
Andrew M
AM
Department of Neurology, Northwestern University Feinberg School of Medicine, 710 N Lake Shore Drive, Eleventh Floor, Chicago, IL 60611, USA. a-naidech@northwestern.edu
D000740:Anemia / Q000188:drug therapy*; D001803:Blood Transfusion; D002543:Cerebral Hemorrhage; D016638:Critical Illness; D006454:Hemoglobins / Q000008:administration & dosage; D006801:Humans; D011446:Prospective Studies
D006454:Hemoglobins